Peterson Maina, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone Demethylases | 4 | 2020 | 328 | 1.160 |
Why?
|
| Genes, myc | 1 | 2016 | 391 | 0.500 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2017 | 1143 | 0.370 |
Why?
|
| Transcription Factors | 4 | 2020 | 12174 | 0.360 |
Why?
|
| Neuroendocrine Tumors | 1 | 2016 | 657 | 0.340 |
Why?
|
| Histones | 2 | 2017 | 2603 | 0.340 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 2 | 2017 | 168 | 0.260 |
Why?
|
| Receptors, Androgen | 2 | 2017 | 1091 | 0.180 |
Why?
|
| Signal Transduction | 3 | 2020 | 23652 | 0.150 |
Why?
|
| Neuroendocrine Cells | 1 | 2017 | 62 | 0.140 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2016 | 85 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 1-alpha | 1 | 2016 | 174 | 0.120 |
Why?
|
| 3' Untranslated Regions | 1 | 2016 | 515 | 0.120 |
Why?
|
| Cell Proliferation | 3 | 2017 | 10486 | 0.100 |
Why?
|
| Lysine | 1 | 2017 | 1000 | 0.100 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2017 | 755 | 0.100 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4291 | 0.100 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 718 | 0.090 |
Why?
|
| Interleukin-6 | 2 | 2020 | 3233 | 0.090 |
Why?
|
| Receptor, erbB-2 | 1 | 2020 | 2606 | 0.080 |
Why?
|
| Cell Cycle | 1 | 2016 | 2937 | 0.080 |
Why?
|
| RNA Interference | 1 | 2016 | 2835 | 0.070 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2017 | 2848 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2020 | 8664 | 0.070 |
Why?
|
| Cell Survival | 1 | 2016 | 5794 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 17174 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5342 | 0.060 |
Why?
|
| MicroRNAs | 2 | 2017 | 3811 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2017 | 7609 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2016 | 4413 | 0.050 |
Why?
|
| Cell Line | 1 | 2017 | 15603 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2016 | 3836 | 0.050 |
Why?
|
| Gene Expression Regulation | 2 | 2017 | 11934 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2016 | 4651 | 0.050 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 21187 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9549 | 0.040 |
Why?
|
| Models, Biological | 1 | 2016 | 9499 | 0.040 |
Why?
|
| Mice | 3 | 2017 | 82074 | 0.030 |
Why?
|
| Acetylation | 1 | 2016 | 1056 | 0.030 |
Why?
|
| Animals | 4 | 2020 | 169408 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14485 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 998 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 1750 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2020 | 4148 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2020 | 2858 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 2004 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2016 | 2576 | 0.020 |
Why?
|
| Humans | 4 | 2020 | 768887 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5216 | 0.010 |
Why?
|
| Male | 2 | 2016 | 365249 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2016 | 19023 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2016 | 11684 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2016 | 22381 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 18366 | 0.010 |
Why?
|
| Female | 3 | 2020 | 397464 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 30266 | 0.010 |
Why?
|